From fasting serum collection to report release, each stage is designed to protect sample quality and keep the doctor involved.
Nutech's approved material states a four-day turnaround from laboratory sample receipt to report. Collection and transport timing can vary by location.
Blood is collected while the patient is fasting. The serum is prepared and shipped through the approved route to the laboratory for analysis.
The sample is processed and its data is inspected against defined quality-control parameters before analysis proceeds.
The biomarker data is processed through a bioinformatics pipeline for classification into presumptive positive or presumptive negative.
The report is generated and sent electronically, or in hard copy when requested, for interpretation through the approved doctor-led pathway.
Sample identity, handling, QC inspection, bioinformatics processing, and responsible report release all contribute to a dependable result.
Patient and sample information should be confirmed before collection and handled through the approved workflow.
A unique sample code supports tracking from collection through laboratory processing and reporting.
Reports are intended for doctor-guided review and must not be treated as a standalone diagnosis.
Your healthcare professional considers the SeroMark-1 index with your broader clinical information and decides whether routine follow-up or additional evaluation is appropriate.
Review who the test is designed forLow band
Example only. Every report requires professional interpretation.
Explore planned collection coverage or contact the Nutech team for help choosing the appropriate route.
